Taichung, Taiwan

Te-hsin Chao

This inventor holds 1 USPTO granted patent. Top assignee: Tunghai University. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Te-hsin Chao: Innovator in Inflammatory Intestinal Disease Treatment

Te-hsin Chao is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical treatment, particularly in addressing inflammatory intestinal diseases. His innovative approach has garnered attention for its potential to improve patient outcomes.

Latest Patents

Te-hsin Chao holds a patent for a method aimed at treating and/or improving inflammatory intestinal disease. This method involves administering a composition that effectively inhibits intestinal bleeding and inflammation in patients. The composition is designed to repair intestinal cells and the intestinal wall structure. It contains an effective amount of bromelain and/or an effective amount of extract, showcasing Chao's commitment to advancing medical treatments.

Career Highlights

Chao is affiliated with Tunghai University, where he contributes to research and development in the medical field. His work is characterized by a focus on innovative solutions that address pressing health issues. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical science.

Collaborations

Te-hsin Chao has collaborated with notable colleagues, including Yesong Gu and Woan-ling Chen. These partnerships enhance the research environment and foster innovation in their shared field of study.

Conclusion

Te-hsin Chao's contributions to the treatment of inflammatory intestinal diseases highlight his role as a key innovator in the medical field. His patented method represents a significant advancement in patient care, demonstrating the impact of dedicated research and collaboration.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…